Zdrowie i gospodarka · 02/12/2011

FDA Releases Draft Guidance on Classification of Pharmaceutical Co-Crystals

The Food and Drug Administration (FDA) has made available a draft guidance for industry on the regulatory classification of pharmaceutical co-crystals, outlining the data and implications for new drug applications and abbreviated new drug applications.